• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    908 Devices Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    6/13/25 4:15:38 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials
    Get the next $MASS alert in real time by email
    false 0001555279 0001555279 2025-06-12 2025-06-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934

     

    Date of Report (Date of Earliest Event Reported): June 12, 2025

     

     

    908 Devices Inc.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware   001-39815   45-4524096

    (State or other jurisdiction
    of incorporation) 

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.) 

     

    645 Summer Street

    Boston, MA  02210

    (Address of principal executive offices, including zip code)

     

    (857) 254-1500
    (Registrant’s telephone number, including area code)

     

    Not Applicable
    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act: 

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, par value $0.001 per share MASS The NASDAQ Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company  x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

     

     

    Item 5.07 Submission of Matters to a Vote of Security Holders.

     

    On June 12, 2025, 908 Devices Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”). As of April 17, 2025, the record date for the 2025 Annual Meeting, there were 35,739,753 shares of the Company’s common stock outstanding and entitled to vote at the 2025 Annual Meeting. A total of 25,290,637 shares of common stock were present or represented by proxy at the 2025 Annual Meeting, representing 70.8% of the issued and outstanding shares entitled to vote at the meeting, representing a quorum. The proposals voted upon, and the final results of the vote were as follows:

     

    Proposal No. 1: Election of Class II Directors. The results were as follows:

     

    Director  For   Withheld   Broker Non-Votes 
    Kevin J. Knopp, Ph.D.  17,097,308   1,653,206   6,540,123 
    Tony J. Hunt  17,286,211   1,464,303   6,540,123 
    Mark Spoto  16,280,761   2,469,753   6,540,123 

     

    Proposal No. 2: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025. The results were as follows:

     

    For   Against   Abstain 
     25,105,612    17,382    167,643 

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: June 13, 2025 908 Devices Inc.
         
      By: /s/ Michael S. Turner
        Name: Michael S. Turner
        Title: Chief Legal and Administrative Officer

     

     

     

    Get the next $MASS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MASS

    DatePrice TargetRatingAnalyst
    11/13/2024$12.00 → $4.00Outperform → Market Perform
    Leerink Partners
    2/7/2023$14.00Overweight
    Stephens
    3/8/2022$40.00 → $30.00Outperform
    SVB Leerink
    10/15/2021Outperform
    Cowen
    More analyst ratings

    $MASS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Knopp Kevin J. bought $66,596 worth of shares (15,000 units at $4.44), increasing direct ownership by 2% to 722,733 units (SEC Form 4)

      4 - 908 Devices Inc. (0001555279) (Issuer)

      5/19/25 4:37:42 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • Director Spoto Mark bought $42,850 worth of shares (10,000 units at $4.29), increasing direct ownership by 19% to 62,971 units (SEC Form 4)

      4 - 908 Devices Inc. (0001555279) (Issuer)

      5/15/25 4:52:08 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • President and CEO Knopp Kevin J. bought $64,788 worth of shares (15,000 units at $4.32), increasing direct ownership by 2% to 707,733 units (SEC Form 4)

      4 - 908 Devices Inc. (0001555279) (Issuer)

      5/14/25 4:28:02 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials

    $MASS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • 908 Devices downgraded by Leerink Partners with a new price target

      Leerink Partners downgraded 908 Devices from Outperform to Market Perform and set a new price target of $4.00 from $12.00 previously

      11/13/24 8:05:47 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • Stephens initiated coverage on 908 Devices with a new price target

      Stephens initiated coverage of 908 Devices with a rating of Overweight and set a new price target of $14.00

      2/7/23 6:37:28 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • SVB Leerink reiterated coverage on 908 Devices with a new price target

      SVB Leerink reiterated coverage of 908 Devices with a rating of Outperform and set a new price target of $30.00 from $40.00 previously

      3/8/22 4:31:59 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials

    $MASS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • 908 Devices Appoints Christopher D. Brown to its Board of Directors

      908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead

      6/16/25 8:00:00 AM ET
      $AAPL
      $MASS
      $RGEN
      $TMO
      Computer Manufacturing
      Technology
      Industrial Machinery/Components
      Industrials
    • Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit

      908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the Metropolitan Washington Council of Governments (COG) has purchased eight XplorIR devices, one for each of the seven counties and District of Columbia, which comprise the COG. The devices were shipped in Q1 2025, with training taking place in Q2 2025. The handheld XplorIR device accurately detects, identifies, and quantifies 5,000 unknown gas and vapor chemical threats in seconds. The device has simple controls, an intuitive display and is built for harsh environments, making it easy for first responders to use in emergency situations. "The XplorIR is a crucial addition t

      6/3/25 7:00:00 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • Romanian Customs Authority Adopts 908 Devices' MX908 for Border Security Operations

      The handheld mass spectrometers are now in active use for trace detection and identification of drugs and explosives for customs and border patrol applications 908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announced that the Romanian Customs Authority has fully deployed 27 MX908 devices across its border operations. The units were delivered earlier this year and are now actively supporting frontline officers with real-time identification of trace chemicals, enhancing the country's ability to monitor cross-border movement and investigate suspicious substances with speed and precision. "We have already experienced the benefits of the MX

      5/28/25 7:00:00 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials

    $MASS
    SEC Filings

    See more
    • 908 Devices Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - 908 Devices Inc. (0001555279) (Filer)

      6/16/25 8:30:24 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • 908 Devices Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - 908 Devices Inc. (0001555279) (Filer)

      6/13/25 4:15:38 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • SEC Form 144 filed by 908 Devices Inc.

      144 - 908 Devices Inc. (0001555279) (Subject)

      6/4/25 4:26:43 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials

    $MASS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Leonhart Michele M.

      4 - 908 Devices Inc. (0001555279) (Issuer)

      6/13/25 4:22:02 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • Director Hrusovsky E Kevin converted options into 11,364 shares, increasing direct ownership by 8% to 151,307 units (SEC Form 4)

      4 - 908 Devices Inc. (0001555279) (Issuer)

      6/13/25 4:21:34 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • Director Hunt Anthony converted options into 11,364 shares, increasing direct ownership by 61% to 30,085 units (SEC Form 4)

      4 - 908 Devices Inc. (0001555279) (Issuer)

      6/13/25 4:21:03 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials

    $MASS
    Financials

    Live finance-specific insights

    See more
    • 908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

      Revenue from continuing operations grew 59% compared to prior year, driven by an increase in product and service revenue 908 Devices Inc. (NASDAQ:MASS) a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2025. "We are off to a strong start in 2025, with first-quarter revenue exceeding our expectations and the transformation to 908 Devices 2.0 already delivering both top-line growth and meaningful cost reductions," said Kevin J. Knopp, CEO and Co-founder. "With a sharpened focus, a strengthened financial position, and macro trends in

      5/13/25 7:00:00 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • 908 Devices Announces Preliminary First Quarter 2025 Financial Results

      At least 55% reported revenue growth from continuing operations compared to prior year 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for safety and defense tech applications, today announced preliminary unaudited financial results for the quarter ended March 31, 2025. Preliminary unaudited revenue from continuing operations for the first quarter of 2025 is expected to be at least $11.5 million, compared to $7.4 million of revenue from continuing operations in the first quarter of 2024, reflecting reported growth of approximately 55%. First quarter revenues do not include approximately $1.1 million of additional re

      4/15/25 7:00:00 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • 908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

      Divested desktop portfolio to Repligen for $70 million, including the MAVEN, MAVERICK, REBEL and ZipChip products Fourth quarter 2024 revenue increases 31% and full year 2024 revenue increases 19% compared to prior year Initiates revenue outlook for 2025 908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year ended December 31, 2024. Strategic Transformation Realized 908 Devices cements its unique position as a market-leading provider of analytical tools for tackling critical public health and safety crises through the divestiture of its bioprocessing desktop assets to

      3/4/25 7:45:00 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials

    $MASS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

      SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

      11/14/24 5:11:18 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

      SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

      11/14/24 4:25:10 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

      SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

      7/8/24 4:32:41 PM ET
      $MASS
      Industrial Machinery/Components
      Industrials

    $MASS
    Leadership Updates

    Live Leadership Updates

    See more
    • 908 Devices Appoints Christopher D. Brown to its Board of Directors

      908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead

      6/16/25 8:00:00 AM ET
      $AAPL
      $MASS
      $RGEN
      $TMO
      Computer Manufacturing
      Technology
      Industrial Machinery/Components
      Industrials
    • 908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

      908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately. Ms. Leonhart brings a deep understanding of our customers in law enforcement and adjacent markets. Her 34-year career in the DEA encompassed various positions with increasing levels of responsibility, including Special Agent in Charge of the Los Angeles Field Division from 1998 to 2003, Deputy Administrator (nominated by President Bush) from 2003 to 2007, Acting Administrator from 2007 to 2010, and Admini

      6/25/24 7:00:00 AM ET
      $MASS
      Industrial Machinery/Components
      Industrials
    • 908 Devices Appoints Tony J. Hunt, President and CEO, Repligen, to its Board of Directors

      908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spectrometry devices for chemical and biomolecular analysis, has appointed Tony J. Hunt, President and CEO, Repligen Corporation (NASDAQ:RGEN), to serve on its Board of Directors effective immediately. Mr. Hunt brings a deep understanding of the bioprocessing market, with more than 20 years of life sciences management experience. He joined Repligen in 2014 as Chief Operating Officer and was promoted to his current role a year later. Mr. Hunt previously was President of Bioproduction at Life Technologies, which was acquired by Thermo Fisher Scientific in 2014. From 2000 to 2008, he was with Applied Biosystems as

      3/2/22 4:30:00 PM ET
      $MASS
      $RGEN
      Industrial Machinery/Components
      Industrials
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care